Trial Information
Radiation Induced Change of Liver Function Measured by Uptake of the Galactose Analogue FDGal and PET/CT
Inclusion Criteria:
- liver tumor
- referred for stereotactic radiation therapy
- age > 18 years
Exclusion Criteria:
- Impaired kidney function
- Pregnancy
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Uptake of FDGal
Outcome Description:
Volumetric uptake of FDGal can be measured is measured by PET/CT
Outcome Time Frame:
Before, 1 month and 3 months after stereotactic radiotherapy
Safety Issue:
No
Principal Investigator
Morten Høyer, MD PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Aarhus University Hospital
Authority:
Denmark: National Board of Health
Study ID:
AarhusLiverRadGal
NCT ID:
NCT01213758
Start Date:
June 2010
Completion Date:
May 2013
Related Keywords:
- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Metastases
- Stereotactic Body Radiotherapy
- liver function
- galactose
- 18-F-deoxy-galactose
- PET/CT
- stereotactic body radiation therapy
- SBRT
- Carcinoma
- Neoplasm Metastasis
- Cholangiocarcinoma
- Carcinoma, Hepatocellular